Media Thread, page-13691

In reply to @kisling1

Here's the opening paragraph from Macquarie's daily stock market report ...

Half-full: IMU fell on a day "meme stocks" apparently rose, so maybe IMU isn't a meme stock after all.

Half-empty: IMU can't even keep up with meme stocks.



FWIW, I reckon Saul Priceman has left because he's lost confidence that Hopper will be able to raise funds to progress Oncarlytics. Still can't believe IMU doesn't think this worthy of an announcement. Then again, I can't remember a single "negative" IMU announcement, even as 90% of the value of the company has been eroded.

The silence from Yuman Fong right when CF33/Vaxinia is getting to the pointy end of the dose escalation trial is also a concern. Is he worried that Phase 1 results won't be strong enough to justify additional funding to progress to Phase II? (and yes, I'm aware that IMU has announced a next Phase trial for in bile duct cancer, but it also announced NextHERIZON, NeoHERIZONandNeuHERIZON) ...